Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14

 

 

Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Dr. Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Research Associate at Feinbeg School of Medicine, Northwestern University, Chicago, IL, USA

Dr. Muhammad Adnan Shereen is a highly accomplished researcher and educator with expertise in microbiology, virology, immunology, and molecular biology. He completed his Ph.D. in Microbiology (Virology) from Wuhan University, China, focusing on the dysregulation of astrocytic genes by the Zika virus. Dr. Shereen has received several prestigious awards and recognitions for his academic achievements, including being ranked among the top 2% most influential scientists in the world by Stanford University. He has published extensively on various aspects of virology and infectious diseases, including the COVID-19 pandemic. Dr. Shereen’s research interests include neurotropic viruses, host-pathogen interactions, and the development of therapeutic options for viral infections. He has a strong background in scientific skills, including culturing and identifying pathogenic microbes, sequencing, animal modeling, and various molecular techniques. Dr. Shereen has also gained teaching experience and has been involved in research supervision at multiple institutions, demonstrating his commitment to education and academic excellence.

Professional Profiles:

Education:

Dr. Muhammad Adnan Shereen pursued his Ph.D. in Microbiology (Virology) from September 2017 to June 2021 at the State Key Laboratory of Virology, Department of Microbiology, College of Life Sciences, Wuhan University, China. His dissertation focused on the dysregulation of astrocytic genes involved in neurodevelopment by the Zika virus. Prior to his Ph.D., Dr. Shereen completed his M.Phil. in Microbiology from September 2013 to June 2015 at the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. His M.Phil. dissertation involved the synthesis and characterization of Miltefosine Loaded Thiolated Nanoparticles for Leishmaniasis Therapy. He obtained his Bachelor of Science (Hons) in Microbiology from The University of Peshawar, Pakistan, from 2009 to 2013. Additionally, Dr. Shereen completed his Higher Secondary School Certificate (Pre-Medical) from Peshawar Model Degree College, Peshawar, Pakistan, from 2005 to 2007.

Professional Experience:

Dr. Muhammad Adnan Shereen is currently a Research Associate/Postdoctoral at the Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, USA. He also serves as a Research Lecturer at Kohsar University of Murree, Pakistan, where he supervises research and teaches various subjects in the Department of Microbiology. Previously, he worked as a Research Lecturer at the University of Haripur, Pakistan, where he also supervised research and taught microbiology-related subjects. During his Ph.D., Dr. Shereen worked as a Research Associate in Professor Jianguo Wu’s lab at the State Key Laboratory of Virology. He has also participated in the CSCB Training Course on Mouse Genetics and Phenotyping, organized by the Model Animal Research Center, Nanjing University, China, and the Chinese Society for Cell Biology. Earlier in his career, Dr. Shereen served as a Demonstrator at Jinnah Medical College, Peshawar, Pakistan, where he taught General Bacteriology, Immunology, and Parasitology. He also gained valuable experience as an Internee at Govt. Lady Reading Hospital, Peshawar, Pakistan, where he worked in the Pathology department, focusing on microbiology, serology, PCR, and ELISA.

Research Interest:

Dr. Muhammad Adnan Shereen possesses a diverse skill set in the field of microbiology and related disciplines. His expertise includes microbiology, virology, molecular biology, and immunology, reflecting a comprehensive understanding of microbial pathogens and their interactions with host organisms. Dr. Shereen is proficient in cell and tissue culture technology, which is crucial for studying the behavior of cells in controlled environments. He has experience in isolating primary cells, a fundamental technique in cell biology and immunology research. His knowledge extends to innate immunity, the body’s first line of defense against pathogens, and the complex interactions between hosts and pathogens. Dr. Shereen is skilled in animal modeling, an essential tool for studying diseases and testing potential treatments in vivo. Additionally, he is adept at bioinformatic analysis, enabling him to process and interpret complex biological data. Overall, Dr. Shereen’s broad range of skills makes him a valuable asset in research settings focused on microbiology and related fields.

Awards and Recognitions:

Dr. Muhammad Adnan Shereen has been recognized for his outstanding contributions and achievements in the field of microbiology and virology. He was ranked among the top 2% most influential scientists in the world by Stanford University in both 2022 and 2023, highlighting the impact of his research and expertise. He was awarded the Chinese Government Scholarship under CSC NO. 2016GXYC42 for his Ph.D. studies, receiving a fully funded scholarship from 2017 to 2021. This prestigious scholarship reflects his academic excellence and dedication to research. Dr. Shereen’s academic achievements were further acknowledged by Wuhan University, where he was the First Prize Winner in Academic Achievement for the year 2020. He also won the “Virology Youth Innovation Award” in 2021 for the highest number of publications during his Ph.D. In recognition of his efforts during the COVID-19 pandemic, Dr. Shereen was honored as one of the “Wuhan University 8 Outstanding Individuals to Fight against Coronavirus,” highlighting his commitment to scientific advancement and public health. He has also received several other awards, including the “Excellent International Student Scholarship for the Year 2018” and the “CSCB Training Course on Mouse Genetics and Phenotyping” certificate, demonstrating his continuous pursuit of excellence in academia and research. Additionally, Dr. Shereen has been acknowledged for his academic prowess, standing as the 2nd position holder in his M.Phil. batch from 2013 to 2015. His acceptance and invitation letters for Ph.D. programs at Huazhong University of Science and Technology and Wuhan University further attest to his academic standing and research potential.

Skills:

Dr. Muhammad Adnan Shereen possesses excellent scientific skills, particularly in Microbiology, Virology, Immunology, and Molecular Biology. He is proficient in culturing and identifying pathogenic microbes, primary cell isolation, various microscopy techniques, sequencing, animal modeling, and molecular biology techniques such as PCRs, blotting assays, and ELISA. Dr. Shereen is also skilled in DNA, RNA, protein, and plasmid extractions, transfection, synthesis of biomaterials, and drug-loaded nanoparticles. His expertise makes him a valuable researcher in biomedical sciences.

Publications:

  1. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
    • Authors: MA Shereen, S Khan, A Kazmi, N Bashir, R Siddique
    • Year: 2020
    • Citations: 5591
  2. Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options
    • Authors: S Khan, R Siddique, MA Shereen, A Ali, J Liu, Q Bai, N Bashir, M Xue
    • Year: 2020
    • Citations: 436
  3. Impact of coronavirus outbreak on psychological health
    • Authors: S Khan, R Siddique, H Li, A Ali, MA Shereen, N Bashir, M Xue
    • Year: 2020
    • Citations: 316
  4. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
    • Authors: M Tian, W Liu, X Li, P Zhao, MA Shereen, C Zhu, S Huang, S Liu, X Yu, …
    • Year: 2021
    • Citations: 151
  5. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
    • Authors: W Wang, D Hu, C Wu, Y Feng, A Li, W Liu, Y Wang, K Chen, M Tian, …
    • Year: 2020
    • Citations: 126
  6. Novel coronavirus: how things are in Wuhan
    • Authors: S Khan, G Nabi, G Han, R Siddique, S Lian, H Shi, N Bashir, A Ali, …
    • Year: 2020
    • Citations: 85
  7. The spread of novel coronavirus has created an alarming situation worldwide
    • Authors: S Khan, R Siddique, A Ali, Q Bai, Z Li, H Li, MA Shereen, M Xue, G Nabi
    • Year: 2020
    • Citations: 71
  8. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production
    • Authors: Z Luo, R Su, W Wang, Y Liang, X Zeng, MA Shereen, N Bashir, Q Zhang, …
    • Year: 2019
    • Citations: 68
  9. Breastfeeding risk from detectable severe acute respiratory syndrome coronavirus 2 in breastmilk
    • Authors: C Zhu, W Liu, H Su, S Li, MA Shereen, Z Lv, Z Niu, D Li, F Liu, Z Luo, …
    • Year: 2020
    • Citations: 60
  10. The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis
    • Authors: R Liu, X Liu, H Han, MA Shereen, Z Niu, D Li, F Liu, K Wu, Z Luo, C Zhu
    • Year: 2020
    • Citations: 53